Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

appCURE (SSH2apps ltd) announces appCURE application delivery via VMware Workspace ONE

February 06, 2023 at 21:03 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

London, United Kingdom Feb 6, 2023 (Issuewire.com) - appCURE today released its integration for VMware Workspace ONE. The appCURE team, with help from VMware, has developed the capability and flexibility to package and deliver MSIX applications quickly for customers using Workspace ONE for the modern management of their desktop PCs.

"We have been working with VMware to enable clients, partners, and managed service providers to migrate and modernise their application workloads to MSIX for desktop users anywhere using the Workspace ONE platform," Steve Horne, CEO, of appCURE. "With the speed of appCURE and the cloud-native modern management capabilities of Workspace ONE, end users can have their applications transitioned at speed and projects completed faster to reduce time and cost to production-ready environments."

appCURE with this release has added the capability to deliver:

Convert SCCM Packages into MSIX and migrate to VMware Workspace ONE
Running capture to MSIX
4000+ applications directly package into Workspace ONE
Certificate creation and package signing
MSIX Smoke testing

appCURE and its unique CURE (Capture, Update, Remediate & Execute) process allow clients to update older, out-of-support operating systems application migrations to support Microsoft operating systems, whilst future proofing against potential problems and vulnerabilities and significantly reducing project timelines.

Modern management with VMware Workspace ONE allows customers to manage the complete PC lifecycle including deployment and onboarding, policies and patching, software delivery, security, and support anywhere with a leader in UEM (unified endpoint management) software.

"Workspace ONE UEM supports full modern application lifecycle management including the delivery of any type of application to Windows devices. We're excited to work with appCURE to make the packaging and delivery of MSIX applications faster, simpler, and more efficient for our customers," Renu Upadhyay, Vice President of Product and Technical Marketing, End User Computing at VMware.

VMware and Workspace ONE are trademarks or registered trademarks of VMware, Inc. in the United States and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective companies.

appCURE is a registered trademark of Ssh2apps limited in the United Kingdom and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective companies.

Media Contact

appCURE (ssh2apps limited)

info@appcure.io

https://www.appcure.io

Source :ssh2apps ltd

This article was originally published by IssueWire. Read the original article here.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article